Alkyl amines chemicals Limited has filed its quarterly compliance certificate with depositories for the quarter ended March 31, 2026, fulfilling regulatory requirements under SEBI (Depositories & Participants) Regulations, 2018. The submission was made on April 7, 2026, to both National Securities Depository Limited and Central Depository Securities (India) Limited.

Regulatory Compliance Confirmation

The company submitted its certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, confirming that details of securities dematerialized during Q4 FY26 have been furnished to stock exchanges where the company's shares are listed. The confirmation was based on verification received from the company's registrar and share transfer agent.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, provided the necessary confirmation on April 3, 2026. The registrar confirmed that securities received from depository participants for dematerialization during Q4 FY26 were properly processed and confirmed to depositories within prescribed timelines.

The registrar's confirmation covered several key compliance aspects:

• Securities received for dematerialization were confirmed or rejected to depositories
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• All processes were completed within prescribed timelines

Stock Exchange Notification

The company has copied both BSE Limited and The National Stock Exchange of India Limited on this compliance filing, ensuring transparency with all relevant market infrastructure institutions. This demonstrates adherence to comprehensive reporting requirements across all platforms where the company's securities are traded.

Corporate Governance

The certificate was signed by Chintamani D. Thatte, General Manager (Legal) & Company Secretary & Compliance Officer, reflecting the company's commitment to maintaining proper corporate governance standards. The digital signature was applied on April 7, 2026, ensuring authenticity and traceability of the regulatory submission.

This quarterly compliance filing represents part of the company's ongoing regulatory obligations and demonstrates systematic adherence to SEBI's depository regulations for securities handling and reporting.

Alkyl amines chemicals Limited has announced the grant of 28,300 employee stock options under its established Employee Stock Option Plan 2018. The Nomination and Remuneration Committee of the Board of Directors approved this grant during its meeting held on March 31, 2026.

Stock Option Grant Details

The company has structured the stock option grant with differentiated pricing to accommodate various employee categories. The grant comprises two distinct pricing tiers designed to provide flexibility in employee compensation.

Pricing Structure and Exercise Terms

The stock options feature a two-tier pricing structure reflecting different employee categories or grant conditions. The majority of options are priced at the higher exercise price, while a smaller portion offers a more favorable rate.

Each stock option converts into one equity share with a face value of Rs.2 each, providing employees with direct ownership participation in the company.

Vesting and Exercise Timeline

The stock option plan incorporates a graduated vesting schedule designed to promote employee retention and long-term commitment. The vesting period spans from 1 year to 4 years, allowing for staggered option maturity.

Key timeline features include:

• Vesting Period: 1 year to 4 years from grant date
• Exercise Window: 5 years from individual vesting date
• Conversion Ratio: 1:1 (one option equals one equity share)

Regulatory Compliance

The stock option grant operates in full compliance with Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. This regulatory alignment ensures proper governance and transparency in the employee benefit program.

The announcement was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating the company's commitment to maintaining transparent communication with stakeholders regarding significant corporate developments.